Ignite Creation Date:
2025-12-26 @ 12:19 PM
Ignite Modification Date:
2025-12-26 @ 12:19 PM
Study NCT ID:
NCT06058000
Status:
COMPLETED
Last Update Posted:
2025-03-12
First Post:
2023-09-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-21
First Submit QC Date:
None
Study First Post Date:
2023-09-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-11
Last Update Post Date:
2025-03-12
Last Update Post Date Type:
ACTUAL